Nebraska Cancer Specialists is a clinical research site located in Grand Island, Nebraska, United States 68803.
Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.
Nebraska Cancer Specialists has participated in 7 clinical trials with 6 currently active.
Therapeutic areas: Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma.
Sponsors: BeiGene, MacroGenics, Hoffmann-La Roche.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Grand Island
Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Cancer Specialists has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Cancer Specialists has 7 clinical trials on record, with 6 currently active. Their work covers Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma.
Nebraska Cancer Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.